人口篩檢市場：按產品類型、應用、性別、年齡層、交付方式、最終用戶和地區分類

預計到 2026 年，人口篩檢市場規模將達到 275.7 億美元，到 2033 年將達到 404.2 億美元。預計從 2026 年到 2033 年，該市場將以 5.6% 的複合年成長率成長。

全球人群篩檢市場正逐漸成為醫療保健領域的重要組成部分，旨在早期發現和預防疾病。人群篩檢透過系統性地檢查無症狀個體，識別出有特定疾病風險的人群，從而實現及時幹預並改善健康狀況。隨著全球面臨慢性病日益增多和醫療保健成本飆升等挑戰，有效的團體篩檢計畫的重要性不言而喻。該市場涵蓋多種篩檢項目，例如基因篩檢、癌症篩檢、心血管疾病篩檢和感染疾病篩檢。隨著人工智慧和基因組學等技術的進步，預計未來幾年群體篩檢市場將迎來顯著成長和創新。

市場動態：

全球人群篩檢市場受多種因素驅動，包括慢性病盛行率上升、人們對疾病早期檢測意識增強以及政府促進醫療保健的措施。癌症、糖尿病和心血管疾病等疾病負擔日益加重，使得人們更需要有效的篩檢計畫來識別高風險族群並及時介入。此外，液態生物檢體、次世代定序和人工智慧影像分析等篩檢技術的進步有望提高檢測的準確性和效率，從而進一步推動市場成長。然而，該市場也面臨一些限制因素，例如篩檢檢測成本高昂、某些地區醫療服務資源有限以及對假陽性和過度診斷的擔憂。此外，圍繞基因篩檢和資料隱私的監管挑戰和倫理考量也可能阻礙市場成長。儘管存在這些挑戰，人群篩檢市場仍為相關人員提供了巨大的成長機會。遠距遠端醫療和遠距監測解決方案的日益普及有望擴大篩檢計畫的覆蓋範圍，尤其是在醫療資源匱乏的地區。此外，將人群篩檢與藥物基因體學和風險分層等個人化醫療方法相結合，能夠實現精準幹預並最佳化患者預後。隨著全球醫療體係日益重視預防醫學和成本效益，預計未來幾年人群篩檢市場將迎來顯著成長和創新。

本研究的主要特點：

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球大規模篩檢市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務績效和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球人口篩檢市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過利用全球人口篩檢市場分析中使用的各種策略矩陣，相關人員可以更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球人口篩檢市場：依產品類型分類，2021-2033年

• 硬體設備
• 檢測或檢查室服務
• 分析或解釋

第5章 全球人口篩檢市場：依應用領域分類，2021-2033年

• 腫瘤學
• 循環系統
• 免疫學
• 神經病學
• 遺傳學和基因組學
• 內分泌與代謝
• 感染疾病
• 生殖健康及孕產婦健康
• 小兒科和新生兒科
• 精神病學和心理健康
• 血液學
• 胃腸病學
• 腎臟病學

第6章 全球人口篩檢市場：依性別分類，2021-2033年

• 男性
• 女士

第7章 全球人口篩檢市場：依年齡層別分類，2021-2033年

• 兒童人口
• 成年人口
• 老年人口

第8章 全球人口篩檢市場：以交付方式分類，2021-2033年

• 現場/設施內篩檢
• 遠距/遠端保健篩檢
• 移動篩檢單元
• 自我測驗/居家測試

第9章 全球人口篩檢市場：依最終使用者分類，2021-2033年

• 醫院
• 診斷檢查室
• 學術研究機構
• 政府和公共衛生機構
• 專科診所
• 其他

第10章 全球人口篩檢市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第11章 競爭格局

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• QIAGEN
• Hologic
• PerkinElmer
• Illumina
• Cepheid
• Genomic Health
• Agilent Technologies
• Ortho Clinical Diagnostics
• Becton, Dickinson and Company
• Beckman Coulter

第12章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第13章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Population Screening Market is estimated to be valued at USD 27.57 Bn in 2026 and is expected to reach USD 40.42 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.

The global population screening market has emerged as a crucial aspect of preventive healthcare, aiming to detect and prevent diseases at an early stage. Population screening involves the systematic testing of asymptomatic individuals to identify those at risk of developing specific conditions, enabling timely intervention and improved health outcomes. As the world faces an increasing burden of chronic diseases and rising healthcare costs, the importance of effective population screening programs cannot be overstated. This market encompasses various screening tests, including genetic screening, cancer screening, cardiovascular screening, and infectious disease screening, among others. With advancements in technology, such as the integration of artificial intelligence and genomics, the population screening market is poised for significant growth and innovation in the coming years.

Market Dynamics:

The global population screening market is driven by several factors, including the rising prevalence of chronic diseases, increasing awareness about early disease detection, and government initiatives to promote preventive healthcare. The growing burden of diseases such as cancer, diabetes, and cardiovascular disorders has heightened the need for effective screening programs to identify at-risk individuals and enable timely intervention. Moreover, advancements in screening technologies, such as liquid biopsy, next-generation sequencing, and AI-powered imaging analysis, are expected to enhance the accuracy and efficiency of screening tests, further driving market growth. However, the market also faces certain restraints, such as high costs associated with screening tests, limited access to healthcare services in certain regions, and concerns regarding false-positive results and overdiagnosis. Additionally, regulatory challenges and ethical considerations surrounding genetic screening and data privacy may pose obstacles to market growth. Despite these challenges, the population screening market presents significant opportunities for stakeholders. The increasing adoption of telehealth and remote monitoring solutions has the potential to expand the reach of screening programs, particularly in underserved areas. Furthermore, the integration of population screening with personalized medicine approaches, such as pharmacogenomics and risk stratification, can enable targeted interventions and optimize patient outcomes. As healthcare systems worldwide focus on preventive care and cost-effectiveness, the population screening market is expected to witness substantial growth and innovation in the coming years.

Key Features of the Study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global population screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Hologic, PerkinElmer, Illumina, Cepheid, Genomic Health, Agilent Technologies, Ortho Clinical Diagnostics, Becton, Dickinson and Company, and Beckman Coulter.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global population screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global population screening market.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
• Hardware Equipment
  • Diagnostic Devices
  • Sample Collection Devices
  • Imaging Equipment
• Testing or Laboratory Services
  • Laboratory Testing Kits
  • Point-of-Care Testing
  • Blood and Urine Testing Services
• Analytics or Interpretation
  • Software Solutions for Data Analysis
  • Interpretation Services
  • Reporting Tools
  • Others
• Application Area Insights (Revenue, USD Bn, 2021 - 2033)
• Oncology
• Cardiology
• Immunology
• Neurology
• Genetics and Genomics
• Endocrinology and Metabolism
• Infectious Diseases
• Reproductive and Maternal Health
• Pediatrics and Neonatology
• Psychiatry and Mental Health
• Hematology
• Gastroenterology
• Nephrology
• Gender Insights (Revenue, USD Bn, 2021 - 2033)
• Male
• Female
• Age Group Insights (Revenue, USD Bn, 2021 - 2033)
• Pediatric Population
• Adult Population
• Elderly Population
• Delivery Mode Insights (Revenue, USD Bn, 2021 - 2033)
• Onsite/Facility-Based Screening
• Remote/Telehealth Screening
• Mobile Screening Units
• Self-Testing/Home-Based
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Hospitals
• Diagnostic Laboratories
• Academic & Research Institutes
• Government and Public Health Agencies
• Specialty Clinics
• Others

Regional Insights (Revenue, USD Bn, 2021 - 2033)

• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• QIAGEN
• Hologic
• PerkinElmer
• Illumina
• Cepheid
• Genomic Health
• Agilent Technologies
• Ortho Clinical Diagnostics
• Becton, Dickinson and Company
• Beckman Coulter

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Population Screening Market, By Product Type
  • Global Population Screening Market, By Application Area
  • Global Population Screening Market, By Gender
  • Global Population Screening Market, By Age Group
  • Global Population Screening Market, By Delivery Mode
  • Global Population Screening Market, By End User
  • Global Population Screening Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Population Screening Market, By Product Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hardware Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Diagnostic Devices
    • Sample Collection Devices
    • Imaging Equipment
• Testing or Laboratory Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Laboratory Testing Kits
    • Point-of-Care Testing
    • Blood and Urine Testing Services
• Analytics or Interpretation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Software Solutions for Data Analysis
    • Interpretation Services
    • Reporting Tools
    • Others

5. Global Population Screening Market, By Application Area, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Genetics and Genomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Endocrinology and Metabolism
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Reproductive and Maternal Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Pediatrics and Neonatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Psychiatry and Mental Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Gastroenterology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Nephrology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Population Screening Market, By Gender, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Population Screening Market, By Age Group, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pediatric Population
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Adult Population
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Elderly Population
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Population Screening Market, By Delivery Mode, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Onsite/Facility-Based Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Remote/Telehealth Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Mobile Screening Units
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Self-Testing/Home-Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Population Screening Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Government and Public Health Agencies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Population Screening Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PerkinElmer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cepheid
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genomic Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ortho Clinical Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beckman Coulter
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us